WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Accelerating Targeted Gene Expression Analysis in Drug Development

Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how microfluidic qPCR bridges the gap between traditional qPCR and sequencing, enabling biomarker research, target validation, and more informed development decisions. | Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how microfluidic qPCR bridges the gap between traditional qPCR and sequencing, enabling biomarker research, target validation, and more informed development decisions.

Raccontata dafiercepharma.comstatnews.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
fiercepharma.comStai leggendo8 h fa

Accelerating Targeted Gene Expression Analysis in Drug Development

Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how microfluidic qPCR bridges the gap between traditional qPCR and sequencing, enabling biomarker…

originale
statnews.com1 g fa

Legend Biotech emerged as a rare market winner

New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 3 giugno 2026·fiercepharma.com

    As Akeso takes center stage at ASCO, China biotech industry cements its coming of age

    In 2017, a little-known company called Nanjing Legend Biotech walked into the ASCO annual meeting at the 11th hour, dropped a 100% objective response rate for a cell therapy that…

  2. mercoledì 3 giugno 2026·statnews.com

    Legend Biotech emerged as a rare market winner

    New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout

  • giovedì 4 giugno 2026·fiercepharma.com

    The power of using AI to transform market research into a sensing engine

    Market research shouldn’t lag behind decisions. With AI, organizations can transform it into a sensing engine, continuously capturing signals, connecting data across studies and…

  • giovedì 4 giugno 2026·fiercepharma.com

    Accelerating Targeted Gene Expression Analysis in Drug Development

    Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how microfluidic qPCR bridges the gap between traditional qPCR…